Severe course of disabling pansclerotic morphea of childhood: Clinical features and therapy;Schwerer verlauf einer mutilierenden pansklerotischen zirkumskripten sklerodermie im kindesalter: Klinik und therapie

Hautarzt

Volumn 50, Issue 2, 1999, Pages 131-135

  Stücker, Markus ^a   Schreiber, Dagmar ^b   Gruss, Claus ^b   Freitag, Marcus ^b   Von Kobyletzki, Gregor ^b   Kerscher, Martina ^b   Altmeyer, Peter ^b  

^a ST JOSEF HOSPITAL   (Germany)

^b NONE

Author keywords

Disabling pansclerotic morphea of childhood; Intravascular calcinosis; Phototherapy; UVA1

Indexed keywords

ARTICLE; HUMAN; MORPHEA; PHOTOTHERAPY; TREATMENT OUTCOME; ULTRAVIOLET A RADIATION;

ADOLESCENT; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MICROSCOPY, ELECTRON; SCLERODERMA, LOCALIZED; SKIN; TREATMENT OUTCOME; ULTRAVIOLET THERAPY;

EID: 0042866763     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001050050877     Document Type: Article

References (22)

1. Arbeitsgruppe Sklerodermie der Arbeitsgemeinschaft Dermatologische Forschung (CS, Altmeyer et al.) (1990) Zur Klassifikation der zirkumskripten Sklerodermie. Hautarzt 41:16-21
2. Brown GE, O'Leary PA (1926) Skin capillaries in scleroderma. Arch Intern Med 36:73-88
3. Diaz-Perez JL, Conolly SM, Winkelmann RK (1980) Disabling pansclerotic morphea of children. Arch Dermatol 116:169-173
4. Gruss C, Stücker M, Kobyletzki G v, Schreiber D, Altmeyer P, Kerscher M (1997) Low dose UVA1 phototherapy in disabling pansderotic morphea of childhood. Br J Dermatol 136:293-294 (letter)
5. Hatamochi A, Ono M, Arakawa M et al (1992) Analysis of collagen gene expression by cultured fibroblasts in morphea. Br J Dermatol 126:216-221
6. Haustein UF, Albrecht M (1993) Zur Epidemiologie und Klinik der systemischen Sklerodertnie. Z Hautkr 68:651-658
7. Haustein UF (1996) Raynaud-Phänomen und Sklerodermie. Hautarzt 17:336-340
8. Hermann G, Wlaschek M, Lange TS, Prenzel K, Goerz G, Scharffetter-Kochanek K (1993) UVA irridiation stimulates the synthesis of various matrix-metalloproteinases (MMPs) in cultured human fibroblasts. Exp Dermatol 2:92-97
9. Kerscher M, Dirschka T, Volkenandt M (1995) Treatment of localized scleroderma by UVA 1 phototherapy. Lancet 346:1166
10. Kerscher M, Volkenandt M, Meurer M, Lehman P, Plewig G, Röcken M, Pisani A, Ortonne JP (1994) Treatment of localized scleroderma by PUVA bath photochemotherapy. Lancet 343:1233
11. Krieg T, Braun-Falco O, Perlish JS, Fleischmejer R (1983) Collagen synthesis in generalized morphea. Arch Dermatol Res 275:393-396
12. Krieg T, Meurer M (1988) Systemic scleroderma clinical and pathophysiologic aspects. J Am Acad Dermato 18:457-481
13. Lacour JP, Vitetta A, Chiquet-Ehrismann B et al (1992) Increased expression of tenascin in the dermis in scleroderma. Br J Dermatol 127:328-334
14. Naeye RL (1963) Pulmonary vascular lesions in systemic sclerosis. Dis Chest 44:374-380
15. Norton WL, Nardo JM (1970) Vascular disease in progressive systemic sclerosis (scleroderma). Ann Intern Med 73:317-324
16. Ohtsuka T, Ishikawa H (1994) Statistical definition of nail fold capillary pattern in patients with systemic sclerosis. Dermatollogy 188:286-289
17. Panz B, Bacharach-Buhles M, el Gammal S, Altmeyer P (1994) Reduction of vessels in localized scleroderma. J Invest Dermatol 103,2:267
18. Petersen MJ, Hansen C, Craig S (1992) Ultraviolet A irradiation stimulates collagenase production in cultured human fibroblasts. J Invest Dermatol 99:440-444
19. Recant L, Lacy P (1964) Clinical pathological conference on scleroderma. Am J Med 36:301-314
20. Sackner MA (1966) Scleroderma. Grune & Stratton, New York
21. Scharffetter K, Wlaschek M, Hogg A, Bolsen K, Schothorst A, Goerz G, Krieg T, Plewig G (1991) UVA irradiation induces collagenase in human dermal fibroblasts in vitro and in vivo. Arch Dermatol Res 283:506-511
22. Scharffetter-Kochanek K, Goldermann R, Lehmann P, Hölzle E, Goerz G (1995) PUVA-therapie in disabling pansclerotic morphea of children. BR J Dermatol 132:83